A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents
Stopped Did not go forward with study.
Conditions
Interventions
Sponsor
U.S. Army Medical Research and Development Command
Collaborators